| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Speech | 31 | 2023 | 133 | 13.590 |
Why?
|
| Speech Perception | 23 | 2023 | 66 | 13.140 |
Why?
|
| Free Tissue Flaps | 37 | 2023 | 372 | 10.370 |
Why?
|
| Auditory Cortex | 13 | 2024 | 38 | 8.510 |
Why?
|
| Mammaplasty | 27 | 2023 | 780 | 7.560 |
Why?
|
| Perforator Flap | 13 | 2023 | 93 | 6.730 |
Why?
|
| Temporal Lobe | 22 | 2023 | 192 | 6.550 |
Why?
|
| Neurosurgical Procedures | 32 | 2022 | 609 | 6.520 |
Why?
|
| Lymphedema | 12 | 2022 | 239 | 5.750 |
Why?
|
| Seizures | 29 | 2023 | 989 | 5.400 |
Why?
|
| Electrocorticography | 17 | 2023 | 72 | 4.400 |
Why?
|
| Brain Mapping | 25 | 2022 | 644 | 4.340 |
Why?
|
| Epilepsy | 26 | 2023 | 883 | 4.130 |
Why?
|
| Cerebral Cortex | 19 | 2023 | 621 | 4.120 |
Why?
|
| Postoperative Complications | 54 | 2023 | 5542 | 3.870 |
Why?
|
| Microsurgery | 13 | 2023 | 244 | 3.550 |
Why?
|
| Motor Cortex | 10 | 2023 | 117 | 3.520 |
Why?
|
| Deep Brain Stimulation | 13 | 2023 | 348 | 3.490 |
Why?
|
| Fibula | 14 | 2023 | 146 | 3.360 |
Why?
|
| Phonetics | 16 | 2023 | 46 | 3.340 |
Why?
|
| Mandibular Reconstruction | 5 | 2023 | 39 | 3.280 |
Why?
|
| Drug Resistant Epilepsy | 11 | 2021 | 181 | 2.970 |
Why?
|
| Acoustic Stimulation | 14 | 2023 | 118 | 2.890 |
Why?
|
| Surgical Flaps | 18 | 2021 | 927 | 2.740 |
Why?
|
| Epilepsies, Partial | 10 | 2021 | 111 | 2.600 |
Why?
|
| Tissue and Organ Harvesting | 10 | 2021 | 148 | 2.560 |
Why?
|
| Neural Prostheses | 3 | 2023 | 6 | 2.490 |
Why?
|
| Speech Acoustics | 5 | 2021 | 10 | 2.440 |
Why?
|
| Humans | 287 | 2024 | 261506 | 2.300 |
Why?
|
| Head and Neck Neoplasms | 17 | 2023 | 3976 | 2.300 |
Why?
|
| Electroencephalography | 25 | 2023 | 898 | 2.110 |
Why?
|
| Brain Neoplasms | 29 | 2023 | 4849 | 2.030 |
Why?
|
| Electric Stimulation | 11 | 2023 | 426 | 2.020 |
Why?
|
| Trigeminal Neuralgia | 5 | 2020 | 42 | 2.000 |
Why?
|
| Language | 7 | 2024 | 309 | 1.940 |
Why?
|
| Brain-Computer Interfaces | 3 | 2021 | 14 | 1.790 |
Why?
|
| Lymphatic Vessels | 4 | 2022 | 143 | 1.790 |
Why?
|
| Adult | 132 | 2023 | 77950 | 1.760 |
Why?
|
| Breast Cancer Lymphedema | 3 | 2022 | 38 | 1.690 |
Why?
|
| Anastomosis, Surgical | 7 | 2022 | 371 | 1.680 |
Why?
|
| Movement | 5 | 2023 | 556 | 1.670 |
Why?
|
| Female | 160 | 2023 | 141928 | 1.660 |
Why?
|
| Broca Area | 3 | 2022 | 7 | 1.620 |
Why?
|
| Microvessels | 5 | 2018 | 135 | 1.610 |
Why?
|
| Electrodes, Implanted | 12 | 2023 | 183 | 1.600 |
Why?
|
| Sensorimotor Cortex | 3 | 2021 | 22 | 1.600 |
Why?
|
| Middle Aged | 122 | 2023 | 86204 | 1.590 |
Why?
|
| Retrospective Studies | 90 | 2023 | 37905 | 1.570 |
Why?
|
| Glioma | 14 | 2022 | 1963 | 1.520 |
Why?
|
| Brain | 20 | 2024 | 4113 | 1.490 |
Why?
|
| Male | 139 | 2022 | 123000 | 1.480 |
Why?
|
| Breast Neoplasms | 19 | 2023 | 15694 | 1.460 |
Why?
|
| Face | 3 | 2023 | 273 | 1.440 |
Why?
|
| Electrodes | 9 | 2023 | 116 | 1.420 |
Why?
|
| Thigh | 3 | 2021 | 172 | 1.410 |
Why?
|
| Treatment Outcome | 75 | 2023 | 32848 | 1.400 |
Why?
|
| Mandible | 7 | 2022 | 188 | 1.380 |
Why?
|
| Pitch Perception | 5 | 2024 | 10 | 1.370 |
Why?
|
| Frontal Lobe | 5 | 2022 | 187 | 1.350 |
Why?
|
| Radiosurgery | 9 | 2020 | 1330 | 1.340 |
Why?
|
| Mastectomy | 13 | 2023 | 1534 | 1.300 |
Why?
|
| Neurons | 9 | 2023 | 2287 | 1.290 |
Why?
|
| Quality of Life | 12 | 2023 | 4532 | 1.270 |
Why?
|
| Head | 4 | 2023 | 249 | 1.220 |
Why?
|
| Evoked Potentials, Auditory | 5 | 2021 | 50 | 1.200 |
Why?
|
| Paralysis | 3 | 2023 | 51 | 1.190 |
Why?
|
| Negative-Pressure Wound Therapy | 2 | 2018 | 35 | 1.180 |
Why?
|
| Breast Implants | 4 | 2022 | 391 | 1.180 |
Why?
|
| Functional Laterality | 10 | 2018 | 316 | 1.180 |
Why?
|
| Epilepsy, Temporal Lobe | 8 | 2018 | 101 | 1.170 |
Why?
|
| Young Adult | 55 | 2021 | 21445 | 1.140 |
Why?
|
| Vagus Nerve Stimulation | 7 | 2021 | 59 | 1.130 |
Why?
|
| Neocortex | 4 | 2022 | 98 | 1.110 |
Why?
|
| Aged | 82 | 2023 | 70117 | 1.110 |
Why?
|
| Craniotomy | 8 | 2023 | 304 | 1.110 |
Why?
|
| Feedback, Sensory | 3 | 2015 | 21 | 1.090 |
Why?
|
| Microvascular Decompression Surgery | 2 | 2017 | 11 | 1.070 |
Why?
|
| Follow-Up Studies | 33 | 2023 | 14889 | 1.070 |
Why?
|
| Amygdala | 4 | 2024 | 127 | 1.060 |
Why?
|
| Nonlinear Dynamics | 2 | 2016 | 78 | 1.050 |
Why?
|
| Models, Neurological | 6 | 2021 | 225 | 1.040 |
Why?
|
| Breast Implantation | 2 | 2018 | 228 | 1.040 |
Why?
|
| Hippocampus | 7 | 2024 | 915 | 1.040 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2022 | 7702 | 1.030 |
Why?
|
| Veins | 4 | 2022 | 157 | 1.030 |
Why?
|
| Stereotaxic Techniques | 2 | 2016 | 172 | 1.030 |
Why?
|
| Gyrus Cinguli | 3 | 2023 | 140 | 1.020 |
Why?
|
| Neck | 4 | 2023 | 383 | 1.010 |
Why?
|
| Mammary Arteries | 2 | 2016 | 64 | 0.990 |
Why?
|
| Preoperative Care | 8 | 2021 | 1529 | 0.980 |
Why?
|
| Ganglioglioma | 3 | 2018 | 41 | 0.980 |
Why?
|
| Nerve Net | 3 | 2018 | 257 | 0.960 |
Why?
|
| Hernia, Abdominal | 2 | 2015 | 41 | 0.960 |
Why?
|
| Adolescent | 54 | 2021 | 31252 | 0.950 |
Why?
|
| Skin Transplantation | 5 | 2019 | 173 | 0.950 |
Why?
|
| Anterior Temporal Lobectomy | 5 | 2018 | 32 | 0.940 |
Why?
|
| Theta Rhythm | 2 | 2021 | 29 | 0.940 |
Why?
|
| Astrocytoma | 4 | 2022 | 321 | 0.930 |
Why?
|
| Music | 1 | 2024 | 36 | 0.930 |
Why?
|
| Hemipelvectomy | 3 | 2020 | 40 | 0.920 |
Why?
|
| Wound Healing | 13 | 2019 | 815 | 0.920 |
Why?
|
| Upper Extremity | 3 | 2021 | 87 | 0.890 |
Why?
|
| Aphasia, Broca | 1 | 2022 | 5 | 0.880 |
Why?
|
| Affect | 3 | 2018 | 288 | 0.880 |
Why?
|
| Neurosurgery | 3 | 2022 | 108 | 0.860 |
Why?
|
| Facial Paralysis | 1 | 2022 | 60 | 0.860 |
Why?
|
| Tissue Engineering | 6 | 2016 | 269 | 0.850 |
Why?
|
| Electric Stimulation Therapy | 4 | 2020 | 116 | 0.840 |
Why?
|
| Prospective Studies | 23 | 2023 | 12873 | 0.840 |
Why?
|
| Malformations of Cortical Development | 2 | 2012 | 57 | 0.840 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 2 | 2019 | 32 | 0.830 |
Why?
|
| Acellular Dermis | 3 | 2022 | 103 | 0.830 |
Why?
|
| Brain Stem Infarctions | 1 | 2021 | 1 | 0.820 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2022 | 882 | 0.820 |
Why?
|
| Dysarthria | 1 | 2021 | 24 | 0.810 |
Why?
|
| Speech Disorders | 2 | 2020 | 91 | 0.790 |
Why?
|
| Lymph Nodes | 6 | 2022 | 2967 | 0.790 |
Why?
|
| Intracranial Arteriovenous Malformations | 4 | 2022 | 41 | 0.790 |
Why?
|
| Tissue Expansion | 2 | 2018 | 71 | 0.790 |
Why?
|
| Sign Language | 1 | 2020 | 2 | 0.770 |
Why?
|
| Auditory Pathways | 2 | 2023 | 18 | 0.770 |
Why?
|
| Epigastric Arteries | 3 | 2020 | 58 | 0.770 |
Why?
|
| Hernia, Ventral | 3 | 2023 | 159 | 0.770 |
Why?
|
| Obesity | 5 | 2023 | 2884 | 0.760 |
Why?
|
| Apraxias | 1 | 2020 | 12 | 0.760 |
Why?
|
| Neoplasms, Neuroepithelial | 2 | 2011 | 27 | 0.760 |
Why?
|
| Salvage Therapy | 6 | 2022 | 2054 | 0.750 |
Why?
|
| Collagen | 5 | 2021 | 752 | 0.740 |
Why?
|
| Larynx | 2 | 2018 | 134 | 0.740 |
Why?
|
| Extremities | 2 | 2022 | 303 | 0.730 |
Why?
|
| Patient Care Planning | 2 | 2019 | 297 | 0.730 |
Why?
|
| Computer-Aided Design | 2 | 2022 | 73 | 0.730 |
Why?
|
| Eyelids | 2 | 2018 | 163 | 0.730 |
Why?
|
| Graft Rejection | 6 | 2023 | 834 | 0.720 |
Why?
|
| Surgical Wound Infection | 5 | 2023 | 450 | 0.710 |
Why?
|
| Chronic Pain | 1 | 2023 | 238 | 0.710 |
Why?
|
| Pituitary Neoplasms | 3 | 2014 | 203 | 0.700 |
Why?
|
| Glioblastoma | 8 | 2023 | 1797 | 0.700 |
Why?
|
| Mandibular Osteotomy | 1 | 2019 | 33 | 0.700 |
Why?
|
| Vascular Surgical Procedures | 2 | 2016 | 655 | 0.700 |
Why?
|
| Osteotomy | 2 | 2020 | 100 | 0.690 |
Why?
|
| Joint Instability | 1 | 2020 | 88 | 0.680 |
Why?
|
| Transplants | 1 | 2019 | 52 | 0.680 |
Why?
|
| Unsupervised Machine Learning | 1 | 2018 | 12 | 0.670 |
Why?
|
| Globus Pallidus | 2 | 2010 | 71 | 0.670 |
Why?
|
| Amputation, Traumatic | 1 | 2018 | 11 | 0.670 |
Why?
|
| Anomia | 2 | 2016 | 3 | 0.670 |
Why?
|
| Leg Injuries | 1 | 2019 | 31 | 0.670 |
Why?
|
| Abdominal Wound Closure Techniques | 2 | 2016 | 40 | 0.660 |
Why?
|
| Venous Thrombosis | 2 | 2020 | 384 | 0.650 |
Why?
|
| Tissue Expansion Devices | 1 | 2018 | 62 | 0.640 |
Why?
|
| Replantation | 1 | 2018 | 61 | 0.640 |
Why?
|
| Bandages | 1 | 2018 | 71 | 0.640 |
Why?
|
| Emotions | 1 | 2022 | 562 | 0.630 |
Why?
|
| Tissue Scaffolds | 6 | 2016 | 135 | 0.620 |
Why?
|
| Transplantation, Autologous | 8 | 2022 | 1914 | 0.620 |
Why?
|
| Intraoperative Complications | 3 | 2016 | 301 | 0.620 |
Why?
|
| Cohort Studies | 20 | 2023 | 9244 | 0.610 |
Why?
|
| Intention | 1 | 2018 | 109 | 0.610 |
Why?
|
| Reoperation | 11 | 2020 | 1382 | 0.610 |
Why?
|
| Dystonia | 2 | 2011 | 163 | 0.610 |
Why?
|
| Skin, Artificial | 1 | 2017 | 25 | 0.600 |
Why?
|
| Aged, 80 and over | 27 | 2021 | 29902 | 0.600 |
Why?
|
| Perceptual Masking | 1 | 2016 | 6 | 0.600 |
Why?
|
| Blepharoplasty | 1 | 2017 | 36 | 0.600 |
Why?
|
| Pain Management | 2 | 2020 | 668 | 0.600 |
Why?
|
| Stem Cells | 6 | 2015 | 1213 | 0.590 |
Why?
|
| Rhizotomy | 2 | 2014 | 13 | 0.590 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 349 | 0.590 |
Why?
|
| Child | 37 | 2023 | 29154 | 0.580 |
Why?
|
| Maxilla | 3 | 2017 | 84 | 0.580 |
Why?
|
| Anatomic Landmarks | 1 | 2016 | 50 | 0.560 |
Why?
|
| Epilepsy, Complex Partial | 3 | 2012 | 18 | 0.560 |
Why?
|
| Space Perception | 1 | 2016 | 77 | 0.560 |
Why?
|
| Polymicrogyria | 1 | 2015 | 3 | 0.560 |
Why?
|
| Sarcoma | 3 | 2022 | 1725 | 0.560 |
Why?
|
| Surgical Instruments | 4 | 2011 | 138 | 0.550 |
Why?
|
| Cerebrum | 1 | 2016 | 44 | 0.550 |
Why?
|
| Algorithms | 8 | 2022 | 3890 | 0.540 |
Why?
|
| Somatosensory Cortex | 2 | 2013 | 68 | 0.540 |
Why?
|
| Omentum | 1 | 2016 | 96 | 0.540 |
Why?
|
| Prosthesis Design | 1 | 2018 | 749 | 0.530 |
Why?
|
| Aphasia | 1 | 2015 | 21 | 0.530 |
Why?
|
| Clinical Decision-Making | 2 | 2017 | 524 | 0.530 |
Why?
|
| Carcinoma, Squamous Cell | 7 | 2022 | 5437 | 0.530 |
Why?
|
| Magnetoencephalography | 3 | 2016 | 37 | 0.530 |
Why?
|
| Tongue Neoplasms | 2 | 2015 | 246 | 0.530 |
Why?
|
| Osteoradionecrosis | 3 | 2017 | 123 | 0.530 |
Why?
|
| Biomedical Engineering | 1 | 2015 | 45 | 0.520 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2010 | 376 | 0.520 |
Why?
|
| Databases, Factual | 3 | 2016 | 2218 | 0.520 |
Why?
|
| Wernicke Area | 1 | 2014 | 11 | 0.520 |
Why?
|
| Glossectomy | 1 | 2015 | 40 | 0.510 |
Why?
|
| Linguistics | 3 | 2021 | 25 | 0.510 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 2 | 2012 | 19 | 0.510 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 66 | 0.510 |
Why?
|
| Ultrasonography, Doppler | 1 | 2016 | 231 | 0.510 |
Why?
|
| Meningioma | 4 | 2015 | 289 | 0.510 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2015 | 54 | 0.510 |
Why?
|
| Fasciotomy | 2 | 2013 | 43 | 0.500 |
Why?
|
| Language Development | 1 | 2014 | 30 | 0.500 |
Why?
|
| Prefrontal Cortex | 4 | 2023 | 229 | 0.500 |
Why?
|
| Hamartoma | 1 | 2015 | 115 | 0.500 |
Why?
|
| Neurosciences | 1 | 2015 | 53 | 0.500 |
Why?
|
| Limb Salvage | 1 | 2015 | 162 | 0.500 |
Why?
|
| Inflammatory Breast Neoplasms | 2 | 2022 | 509 | 0.500 |
Why?
|
| Laser Therapy | 2 | 2016 | 411 | 0.500 |
Why?
|
| Graft Survival | 7 | 2018 | 1062 | 0.500 |
Why?
|
| Supratentorial Neoplasms | 2 | 2015 | 78 | 0.490 |
Why?
|
| Datasets as Topic | 1 | 2015 | 181 | 0.490 |
Why?
|
| Temporal Arteries | 1 | 2014 | 40 | 0.490 |
Why?
|
| Spinal Neoplasms | 1 | 2020 | 631 | 0.490 |
Why?
|
| Adipose Tissue | 7 | 2022 | 769 | 0.490 |
Why?
|
| Electrosurgery | 2 | 2011 | 28 | 0.480 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2014 | 272 | 0.480 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 338 | 0.480 |
Why?
|
| Ear Neoplasms | 1 | 2014 | 59 | 0.480 |
Why?
|
| Neovascularization, Physiologic | 7 | 2016 | 345 | 0.480 |
Why?
|
| Wakefulness | 6 | 2023 | 150 | 0.480 |
Why?
|
| Communication | 2 | 2023 | 876 | 0.470 |
Why?
|
| Dermatofibrosarcoma | 1 | 2014 | 72 | 0.470 |
Why?
|
| Neoplasm Recurrence, Local | 10 | 2023 | 10035 | 0.470 |
Why?
|
| Monitoring, Physiologic | 2 | 2018 | 502 | 0.470 |
Why?
|
| Child, Preschool | 23 | 2021 | 16273 | 0.470 |
Why?
|
| Drug Resistance | 4 | 2014 | 587 | 0.470 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2015 | 222 | 0.470 |
Why?
|
| Evoked Potentials, Motor | 1 | 2013 | 58 | 0.460 |
Why?
|
| Pancreas Transplantation | 3 | 2023 | 46 | 0.460 |
Why?
|
| Vocabulary | 2 | 2023 | 23 | 0.460 |
Why?
|
| Forearm | 3 | 2023 | 67 | 0.460 |
Why?
|
| Pitch Discrimination | 1 | 2013 | 4 | 0.460 |
Why?
|
| Bone Transplantation | 5 | 2020 | 134 | 0.460 |
Why?
|
| Phonation | 1 | 2013 | 9 | 0.450 |
Why?
|
| Risk Factors | 17 | 2021 | 17523 | 0.450 |
Why?
|
| Neural Pathways | 3 | 2023 | 298 | 0.450 |
Why?
|
| Ulnar Artery | 3 | 2023 | 11 | 0.440 |
Why?
|
| Mouth Neoplasms | 4 | 2022 | 713 | 0.440 |
Why?
|
| Depression | 2 | 2023 | 1715 | 0.440 |
Why?
|
| Surgery, Plastic | 1 | 2018 | 344 | 0.430 |
Why?
|
| Quality Improvement | 2 | 2016 | 851 | 0.430 |
Why?
|
| Prognosis | 15 | 2020 | 21713 | 0.430 |
Why?
|
| Auditory Perception | 3 | 2023 | 35 | 0.430 |
Why?
|
| Voice | 2 | 2023 | 23 | 0.430 |
Why?
|
| Anterior Thalamic Nuclei | 1 | 2012 | 4 | 0.430 |
Why?
|
| Microcirculation | 2 | 2013 | 200 | 0.430 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 2012 | 11 | 0.430 |
Why?
|
| Thrombosis | 2 | 2016 | 781 | 0.420 |
Why?
|
| Neurogenesis | 3 | 2019 | 238 | 0.420 |
Why?
|
| Kidney Transplantation | 3 | 2016 | 755 | 0.420 |
Why?
|
| Psychomotor Performance | 3 | 2021 | 233 | 0.420 |
Why?
|
| Morbidity | 4 | 2023 | 397 | 0.420 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 231 | 0.420 |
Why?
|
| Cephalometry | 1 | 2012 | 39 | 0.420 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 1270 | 0.410 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 945 | 0.410 |
Why?
|
| Poloxamer | 1 | 2011 | 15 | 0.410 |
Why?
|
| Postoperative Care | 1 | 2016 | 739 | 0.410 |
Why?
|
| Arteriovenous Malformations | 2 | 2009 | 70 | 0.400 |
Why?
|
| Logistic Models | 6 | 2016 | 3441 | 0.400 |
Why?
|
| Subthalamic Nucleus | 1 | 2012 | 57 | 0.400 |
Why?
|
| Mandibular Diseases | 1 | 2011 | 45 | 0.390 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 81 | 0.390 |
Why?
|
| Time Factors | 14 | 2020 | 12926 | 0.390 |
Why?
|
| Cues | 2 | 2023 | 192 | 0.380 |
Why?
|
| Myocutaneous Flap | 3 | 2017 | 30 | 0.380 |
Why?
|
| Embolism, Air | 1 | 2011 | 33 | 0.380 |
Why?
|
| Arm | 3 | 2023 | 147 | 0.370 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 2403 | 0.370 |
Why?
|
| Dopamine Antagonists | 1 | 2010 | 52 | 0.370 |
Why?
|
| Osseointegration | 1 | 2010 | 21 | 0.370 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2010 | 16 | 0.370 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2010 | 46 | 0.370 |
Why?
|
| Bone Substitutes | 1 | 2010 | 15 | 0.370 |
Why?
|
| Attention | 1 | 2012 | 281 | 0.370 |
Why?
|
| Biomechanical Phenomena | 4 | 2021 | 338 | 0.370 |
Why?
|
| Interneurons | 2 | 2024 | 144 | 0.370 |
Why?
|
| Cortical Synchronization | 1 | 2009 | 13 | 0.370 |
Why?
|
| Action Potentials | 3 | 2022 | 560 | 0.370 |
Why?
|
| Cognition | 4 | 2023 | 968 | 0.360 |
Why?
|
| Occipital Bone | 1 | 2009 | 23 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor A | 9 | 2015 | 1533 | 0.350 |
Why?
|
| Fat Necrosis | 2 | 2022 | 63 | 0.350 |
Why?
|
| Cranial Sinuses | 1 | 2009 | 24 | 0.350 |
Why?
|
| Catheter Ablation | 2 | 2014 | 620 | 0.340 |
Why?
|
| Hand | 2 | 2021 | 170 | 0.340 |
Why?
|
| Edema | 2 | 2021 | 267 | 0.340 |
Why?
|
| Dura Mater | 1 | 2009 | 73 | 0.340 |
Why?
|
| Endothelium, Vascular | 3 | 2009 | 891 | 0.330 |
Why?
|
| Goals | 1 | 2010 | 185 | 0.330 |
Why?
|
| Cell Polarity | 1 | 2010 | 208 | 0.330 |
Why?
|
| Lower Extremity | 3 | 2022 | 299 | 0.330 |
Why?
|
| Scalp | 2 | 2023 | 156 | 0.330 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 114 | 0.330 |
Why?
|
| Hypoxia | 3 | 2010 | 443 | 0.330 |
Why?
|
| Monitoring, Intraoperative | 4 | 2013 | 264 | 0.330 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 4975 | 0.330 |
Why?
|
| Aorta | 2 | 2015 | 692 | 0.320 |
Why?
|
| Adenoma | 3 | 2014 | 716 | 0.320 |
Why?
|
| Noise | 3 | 2016 | 29 | 0.320 |
Why?
|
| Mandibular Neoplasms | 2 | 2019 | 76 | 0.310 |
Why?
|
| Skin | 6 | 2019 | 1259 | 0.310 |
Why?
|
| Trachea | 3 | 2015 | 259 | 0.310 |
Why?
|
| Abdominal Muscles | 1 | 2007 | 68 | 0.300 |
Why?
|
| Meningeal Neoplasms | 2 | 2009 | 441 | 0.300 |
Why?
|
| Longitudinal Studies | 5 | 2018 | 1945 | 0.290 |
Why?
|
| Endothelial Cells | 5 | 2022 | 1048 | 0.290 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2006 | 3 | 0.290 |
Why?
|
| Extracellular Matrix | 3 | 2016 | 554 | 0.290 |
Why?
|
| Mastectomy, Segmental | 1 | 2012 | 1026 | 0.280 |
Why?
|
| Abdominal Wall | 2 | 2023 | 184 | 0.280 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 441 | 0.280 |
Why?
|
| Reaction Time | 2 | 2021 | 234 | 0.280 |
Why?
|
| Animals | 37 | 2024 | 59536 | 0.280 |
Why?
|
| Angiography | 3 | 2019 | 360 | 0.280 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2006 | 49 | 0.280 |
Why?
|
| Neoplasms | 4 | 2023 | 15193 | 0.280 |
Why?
|
| Pain Measurement | 3 | 2020 | 953 | 0.280 |
Why?
|
| Analysis of Variance | 3 | 2015 | 2307 | 0.280 |
Why?
|
| Body Mass Index | 3 | 2022 | 2203 | 0.270 |
Why?
|
| Rats | 11 | 2015 | 6086 | 0.270 |
Why?
|
| Recurrence | 7 | 2023 | 4758 | 0.270 |
Why?
|
| Hemangioma | 1 | 2007 | 154 | 0.260 |
Why?
|
| Fascia | 2 | 2016 | 68 | 0.260 |
Why?
|
| Neural Inhibition | 1 | 2005 | 147 | 0.250 |
Why?
|
| Skull Base | 1 | 2006 | 199 | 0.250 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 224 | 0.250 |
Why?
|
| Craniocerebral Trauma | 1 | 2006 | 130 | 0.250 |
Why?
|
| Microglia | 2 | 2016 | 164 | 0.250 |
Why?
|
| Orbit Evisceration | 2 | 2014 | 46 | 0.240 |
Why?
|
| Radiotherapy, Adjuvant | 4 | 2023 | 2231 | 0.240 |
Why?
|
| United States | 7 | 2022 | 15433 | 0.240 |
Why?
|
| Arteries | 2 | 2022 | 274 | 0.240 |
Why?
|
| Gestures | 1 | 2023 | 7 | 0.240 |
Why?
|
| Parkinson Disease | 1 | 2011 | 708 | 0.240 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 1581 | 0.230 |
Why?
|
| Cell Movement | 3 | 2010 | 2466 | 0.230 |
Why?
|
| Hemangioma, Cavernous | 1 | 2023 | 27 | 0.230 |
Why?
|
| Anticonvulsants | 4 | 2014 | 431 | 0.230 |
Why?
|
| Electromagnetic Fields | 3 | 2009 | 50 | 0.230 |
Why?
|
| Carcinoma | 1 | 2015 | 2578 | 0.230 |
Why?
|
| Thrombectomy | 3 | 2018 | 158 | 0.220 |
Why?
|
| Arousal | 1 | 2023 | 120 | 0.220 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2022 | 255 | 0.220 |
Why?
|
| Predictive Value of Tests | 7 | 2014 | 4892 | 0.220 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2023 | 480 | 0.220 |
Why?
|
| Estrogens | 1 | 2007 | 751 | 0.220 |
Why?
|
| Facial Nerve | 1 | 2022 | 64 | 0.220 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2023 | 136 | 0.220 |
Why?
|
| Groin | 1 | 2022 | 74 | 0.210 |
Why?
|
| Learning | 2 | 2021 | 403 | 0.210 |
Why?
|
| Clinical Protocols | 2 | 2021 | 467 | 0.210 |
Why?
|
| Esthetics | 1 | 2023 | 189 | 0.210 |
Why?
|
| Psychometrics | 2 | 2021 | 937 | 0.210 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2023 | 799 | 0.210 |
Why?
|
| Subdural Space | 1 | 2021 | 7 | 0.210 |
Why?
|
| Printing, Three-Dimensional | 1 | 2023 | 129 | 0.210 |
Why?
|
| Lymphatic System | 1 | 2021 | 64 | 0.210 |
Why?
|
| Stem Cell Transplantation | 2 | 2012 | 1360 | 0.210 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2021 | 32 | 0.210 |
Why?
|
| Microtechnology | 1 | 2021 | 12 | 0.210 |
Why?
|
| Research Design | 1 | 2009 | 1544 | 0.210 |
Why?
|
| Risk Assessment | 4 | 2021 | 6869 | 0.210 |
Why?
|
| Pelvic Bones | 2 | 2020 | 95 | 0.200 |
Why?
|
| Septum of Brain | 1 | 2021 | 5 | 0.200 |
Why?
|
| Vagus Nerve | 1 | 2021 | 63 | 0.200 |
Why?
|
| Quadriplegia | 1 | 2021 | 43 | 0.200 |
Why?
|
| Scapula | 1 | 2021 | 37 | 0.200 |
Why?
|
| Perception | 1 | 2023 | 350 | 0.200 |
Why?
|
| Cells, Cultured | 11 | 2022 | 5637 | 0.200 |
Why?
|
| Incidence | 4 | 2019 | 5673 | 0.200 |
Why?
|
| Laryngectomy | 2 | 2020 | 242 | 0.200 |
Why?
|
| Esophagus | 2 | 2015 | 553 | 0.200 |
Why?
|
| Blood Vessels | 1 | 2022 | 217 | 0.190 |
Why?
|
| Recovery of Function | 5 | 2017 | 703 | 0.190 |
Why?
|
| Mastectomy, Simple | 1 | 2021 | 58 | 0.190 |
Why?
|
| Lipectomy | 2 | 2019 | 63 | 0.190 |
Why?
|
| Behavior | 1 | 2021 | 103 | 0.190 |
Why?
|
| Neural Stem Cells | 2 | 2019 | 181 | 0.190 |
Why?
|
| Infant | 8 | 2019 | 13310 | 0.190 |
Why?
|
| Implantable Neurostimulators | 1 | 2020 | 18 | 0.190 |
Why?
|
| Oncology Service, Hospital | 1 | 2020 | 48 | 0.190 |
Why?
|
| Transplant Donor Site | 1 | 2020 | 11 | 0.190 |
Why?
|
| Osteoblasts | 3 | 2009 | 370 | 0.190 |
Why?
|
| Natural Language Processing | 1 | 2021 | 119 | 0.190 |
Why?
|
| Calcium Phosphates | 2 | 2010 | 19 | 0.190 |
Why?
|
| Oligodendroglioma | 3 | 2015 | 106 | 0.180 |
Why?
|
| Age of Onset | 2 | 2012 | 827 | 0.180 |
Why?
|
| Phonons | 1 | 2019 | 1 | 0.180 |
Why?
|
| Medical History Taking | 1 | 2021 | 173 | 0.180 |
Why?
|
| Inguinal Canal | 1 | 2020 | 60 | 0.180 |
Why?
|
| Cicatrix | 2 | 2014 | 208 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2015 | 6207 | 0.180 |
Why?
|
| Radial Artery | 1 | 2020 | 50 | 0.180 |
Why?
|
| Disease Progression | 6 | 2023 | 6682 | 0.180 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2019 | 7 | 0.180 |
Why?
|
| Speech Articulation Tests | 1 | 2019 | 8 | 0.180 |
Why?
|
| Radiography | 5 | 2020 | 1904 | 0.180 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 22 | 0.180 |
Why?
|
| Operative Time | 2 | 2019 | 217 | 0.180 |
Why?
|
| Trismus | 1 | 2019 | 24 | 0.180 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2021 | 137 | 0.170 |
Why?
|
| Speech Intelligibility | 1 | 2019 | 40 | 0.170 |
Why?
|
| Pulmonary Embolism | 1 | 2023 | 329 | 0.170 |
Why?
|
| Corpus Callosum | 2 | 2010 | 138 | 0.170 |
Why?
|
| Aging | 4 | 2009 | 1582 | 0.170 |
Why?
|
| Combined Modality Therapy | 5 | 2016 | 8865 | 0.170 |
Why?
|
| Skull | 2 | 2023 | 231 | 0.170 |
Why?
|
| Adolescent Development | 1 | 2019 | 34 | 0.170 |
Why?
|
| Indocyanine Green | 1 | 2020 | 117 | 0.170 |
Why?
|
| Saline Waters | 1 | 2018 | 1 | 0.170 |
Why?
|
| Physical Examination | 1 | 2021 | 299 | 0.170 |
Why?
|
| Lacrimal Apparatus | 1 | 2021 | 181 | 0.170 |
Why?
|
| Bone Neoplasms | 3 | 2020 | 2576 | 0.170 |
Why?
|
| Contraindications, Procedure | 1 | 2018 | 8 | 0.170 |
Why?
|
| Parvalbumins | 1 | 2018 | 30 | 0.170 |
Why?
|
| Skin Neoplasms | 2 | 2016 | 4654 | 0.170 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2020 | 158 | 0.170 |
Why?
|
| Silicone Gels | 1 | 2018 | 28 | 0.170 |
Why?
|
| Genetic Counseling | 1 | 2021 | 380 | 0.160 |
Why?
|
| Jaw | 1 | 2018 | 20 | 0.160 |
Why?
|
| Anxiety | 3 | 2024 | 1179 | 0.160 |
Why?
|
| Eye Neoplasms | 1 | 2021 | 247 | 0.160 |
Why?
|
| Lip | 1 | 2018 | 33 | 0.160 |
Why?
|
| Aftercare | 1 | 2020 | 259 | 0.160 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 292 | 0.160 |
Why?
|
| Spine | 1 | 2020 | 293 | 0.160 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2018 | 209 | 0.160 |
Why?
|
| Tongue | 1 | 2018 | 77 | 0.160 |
Why?
|
| Regional Blood Flow | 2 | 2016 | 276 | 0.160 |
Why?
|
| Ischemia | 3 | 2018 | 391 | 0.150 |
Why?
|
| Surgical Mesh | 2 | 2023 | 209 | 0.150 |
Why?
|
| Lactic Acid | 2 | 2018 | 305 | 0.150 |
Why?
|
| Endoscopy | 1 | 2021 | 479 | 0.150 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2016 | 3890 | 0.150 |
Why?
|
| Transcriptome | 3 | 2022 | 1859 | 0.150 |
Why?
|
| Malate Dehydrogenase | 1 | 2017 | 21 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 253 | 0.150 |
Why?
|
| Clinical Coding | 1 | 2016 | 28 | 0.140 |
Why?
|
| Deglutition | 2 | 2015 | 171 | 0.140 |
Why?
|
| Gamma Rhythm | 1 | 2016 | 13 | 0.140 |
Why?
|
| Prolactin | 2 | 2014 | 155 | 0.140 |
Why?
|
| Models, Animal | 2 | 2011 | 664 | 0.140 |
Why?
|
| Adipocytes | 2 | 2015 | 305 | 0.140 |
Why?
|
| Palate | 1 | 2016 | 22 | 0.140 |
Why?
|
| Lymphography | 1 | 2016 | 51 | 0.140 |
Why?
|
| Abdomen | 1 | 2018 | 332 | 0.140 |
Why?
|
| Fourier Analysis | 1 | 2016 | 94 | 0.140 |
Why?
|
| Survival Rate | 6 | 2023 | 12221 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 471 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2022 | 6100 | 0.140 |
Why?
|
| Vascularized Composite Allotransplantation | 1 | 2016 | 29 | 0.140 |
Why?
|
| Probability | 2 | 2016 | 866 | 0.140 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 83 | 0.140 |
Why?
|
| Eyelid Neoplasms | 1 | 2018 | 191 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2010 | 271 | 0.140 |
Why?
|
| Mice | 18 | 2024 | 34495 | 0.140 |
Why?
|
| Neuronal Plasticity | 3 | 2020 | 304 | 0.140 |
Why?
|
| Mouth | 1 | 2017 | 122 | 0.140 |
Why?
|
| Cadaver | 1 | 2016 | 237 | 0.140 |
Why?
|
| Polyglycolic Acid | 1 | 2015 | 34 | 0.130 |
Why?
|
| Mexico | 1 | 2016 | 259 | 0.130 |
Why?
|
| Leg | 1 | 2017 | 226 | 0.130 |
Why?
|
| Encephalocele | 1 | 2015 | 53 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2023 | 862 | 0.130 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2008 | 223 | 0.130 |
Why?
|
| Facial Neoplasms | 1 | 2016 | 84 | 0.130 |
Why?
|
| Vocalization, Animal | 1 | 2015 | 25 | 0.130 |
Why?
|
| Hand Strength | 3 | 2023 | 65 | 0.130 |
Why?
|
| Axons | 1 | 2018 | 403 | 0.130 |
Why?
|
| Body Weight | 1 | 2020 | 1293 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 330 | 0.130 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 356 | 0.130 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2015 | 220 | 0.130 |
Why?
|
| Brain Waves | 1 | 2016 | 50 | 0.130 |
Why?
|
| Orbital Neoplasms | 2 | 2014 | 224 | 0.130 |
Why?
|
| Pectoralis Muscles | 1 | 2015 | 27 | 0.130 |
Why?
|
| Oligodendroglia | 1 | 2015 | 96 | 0.130 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 6009 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 4298 | 0.130 |
Why?
|
| Hyperprolactinemia | 1 | 2014 | 15 | 0.130 |
Why?
|
| Cattle | 2 | 2022 | 783 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2020 | 585 | 0.130 |
Why?
|
| Canada | 1 | 2016 | 429 | 0.130 |
Why?
|
| Evoked Potentials | 1 | 2016 | 190 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2009 | 825 | 0.130 |
Why?
|
| Orbit | 1 | 2016 | 205 | 0.130 |
Why?
|
| Pregnancy, Twin | 1 | 2015 | 118 | 0.130 |
Why?
|
| Age Factors | 4 | 2014 | 5377 | 0.130 |
Why?
|
| Medical Records | 1 | 2016 | 415 | 0.120 |
Why?
|
| Neuroimaging | 2 | 2015 | 403 | 0.120 |
Why?
|
| Ear, External | 1 | 2014 | 42 | 0.120 |
Why?
|
| Cardiac Output | 1 | 2015 | 194 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2019 | 925 | 0.120 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 92 | 0.120 |
Why?
|
| Arthroplasty | 1 | 2014 | 19 | 0.120 |
Why?
|
| Wrist Joint | 1 | 2014 | 30 | 0.120 |
Why?
|
| Rats, Nude | 2 | 2015 | 32 | 0.120 |
Why?
|
| Jejunum | 1 | 2015 | 216 | 0.120 |
Why?
|
| Brachiocephalic Veins | 1 | 2013 | 21 | 0.120 |
Why?
|
| Prolactinoma | 2 | 2014 | 11 | 0.120 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2013 | 1 | 0.120 |
Why?
|
| Anesthesia, General | 1 | 2015 | 239 | 0.120 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2014 | 60 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 295 | 0.120 |
Why?
|
| Elbow Joint | 1 | 2014 | 42 | 0.120 |
Why?
|
| Pharynx | 1 | 2014 | 153 | 0.120 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 1178 | 0.120 |
Why?
|
| Energy Metabolism | 2 | 2018 | 992 | 0.120 |
Why?
|
| Frostbite | 1 | 2013 | 2 | 0.120 |
Why?
|
| Consciousness | 1 | 2013 | 56 | 0.120 |
Why?
|
| Pyramidal Tracts | 1 | 2013 | 57 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2015 | 7551 | 0.110 |
Why?
|
| Electromagnetic Phenomena | 1 | 2013 | 18 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 2594 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2017 | 451 | 0.110 |
Why?
|
| Internship and Residency | 2 | 2022 | 1375 | 0.110 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 500 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 854 | 0.110 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2013 | 156 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 3719 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 1323 | 0.110 |
Why?
|
| Patient Selection | 1 | 2021 | 2055 | 0.110 |
Why?
|
| Rhinoplasty | 1 | 2016 | 148 | 0.110 |
Why?
|
| Thoracic Wall | 1 | 2015 | 183 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 4971 | 0.110 |
Why?
|
| Rectus Abdominis | 1 | 2013 | 100 | 0.110 |
Why?
|
| Sound Spectrography | 1 | 2012 | 8 | 0.110 |
Why?
|
| General Surgery | 1 | 2016 | 326 | 0.110 |
Why?
|
| Models, Biological | 2 | 2018 | 3254 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 552 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 303 | 0.110 |
Why?
|
| Principal Component Analysis | 1 | 2013 | 218 | 0.110 |
Why?
|
| Astrocytes | 1 | 2015 | 368 | 0.110 |
Why?
|
| Learning Curve | 1 | 2012 | 68 | 0.110 |
Why?
|
| Acoustics | 1 | 2012 | 42 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2015 | 577 | 0.110 |
Why?
|
| Epilepsy, Generalized | 1 | 2012 | 71 | 0.100 |
Why?
|
| Rheology | 1 | 2011 | 55 | 0.100 |
Why?
|
| Pain | 1 | 2020 | 1658 | 0.100 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 615 | 0.100 |
Why?
|
| Phase Transition | 1 | 2011 | 17 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2013 | 388 | 0.100 |
Why?
|
| Tissue Donors | 1 | 2016 | 769 | 0.100 |
Why?
|
| Chemokine CXCL12 | 2 | 2009 | 132 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2017 | 1442 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2011 | 37 | 0.100 |
Why?
|
| Postoperative Period | 2 | 2011 | 665 | 0.100 |
Why?
|
| Electrophysiology | 1 | 2012 | 333 | 0.100 |
Why?
|
| Cerebral Angiography | 2 | 2009 | 129 | 0.100 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 551 | 0.100 |
Why?
|
| Supine Position | 1 | 2011 | 46 | 0.100 |
Why?
|
| Psychoacoustics | 1 | 2010 | 5 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 1283 | 0.100 |
Why?
|
| Osteomyelitis | 1 | 2014 | 236 | 0.100 |
Why?
|
| Dyslexia | 1 | 2011 | 24 | 0.100 |
Why?
|
| Therapeutic Irrigation | 1 | 2011 | 90 | 0.100 |
Why?
|
| Diabetes Mellitus | 2 | 2010 | 1054 | 0.100 |
Why?
|
| Disease-Free Survival | 2 | 2015 | 10001 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 2063 | 0.090 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 5159 | 0.090 |
Why?
|
| Ceramics | 1 | 2010 | 11 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2010 | 4320 | 0.090 |
Why?
|
| Time and Motion Studies | 2 | 2021 | 43 | 0.090 |
Why?
|
| Necrosis | 3 | 2023 | 580 | 0.090 |
Why?
|
| Odds Ratio | 2 | 2013 | 2316 | 0.090 |
Why?
|
| Multimodal Imaging | 1 | 2014 | 550 | 0.090 |
Why?
|
| Diabetes Complications | 2 | 2009 | 305 | 0.090 |
Why?
|
| Bone Regeneration | 1 | 2010 | 32 | 0.090 |
Why?
|
| Basal Ganglia | 1 | 2010 | 64 | 0.090 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2011 | 129 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2010 | 246 | 0.090 |
Why?
|
| Filtration | 2 | 2021 | 92 | 0.090 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 388 | 0.090 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 170 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2016 | 787 | 0.090 |
Why?
|
| Minerals | 1 | 2010 | 71 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 1491 | 0.090 |
Why?
|
| Contraindications | 1 | 2010 | 150 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2010 | 63 | 0.090 |
Why?
|
| Absorbable Implants | 1 | 2010 | 65 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2016 | 1171 | 0.090 |
Why?
|
| Risk Management | 1 | 2010 | 107 | 0.090 |
Why?
|
| Culture Media, Conditioned | 4 | 2015 | 260 | 0.090 |
Why?
|
| Comorbidity | 1 | 2016 | 2352 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2008 | 4988 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 7548 | 0.090 |
Why?
|
| Inflammation | 3 | 2022 | 2522 | 0.090 |
Why?
|
| Blindness, Cortical | 1 | 2009 | 16 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2016 | 1335 | 0.090 |
Why?
|
| Thalamus | 1 | 2010 | 132 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 4 | 2012 | 1547 | 0.090 |
Why?
|
| Intracranial Hemorrhages | 1 | 2010 | 121 | 0.090 |
Why?
|
| Infant, Newborn | 3 | 2019 | 8223 | 0.090 |
Why?
|
| Karnofsky Performance Status | 1 | 2009 | 175 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2014 | 1529 | 0.090 |
Why?
|
| Disease Models, Animal | 6 | 2013 | 7222 | 0.090 |
Why?
|
| Occipital Lobe | 1 | 2009 | 48 | 0.090 |
Why?
|
| Nephrectomy | 1 | 2014 | 779 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2010 | 445 | 0.090 |
Why?
|
| Mood Disorders | 1 | 2010 | 163 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2010 | 259 | 0.080 |
Why?
|
| Receptors, Leptin | 1 | 2009 | 62 | 0.080 |
Why?
|
| Nervous System Diseases | 2 | 2010 | 500 | 0.080 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2009 | 106 | 0.080 |
Why?
|
| Bioreactors | 1 | 2008 | 49 | 0.080 |
Why?
|
| Visual Cortex | 1 | 2010 | 136 | 0.080 |
Why?
|
| Pregnancy | 2 | 2015 | 7573 | 0.080 |
Why?
|
| Dissection | 1 | 2009 | 156 | 0.080 |
Why?
|
| Dopamine Agonists | 1 | 2009 | 85 | 0.080 |
Why?
|
| Machine Learning | 2 | 2023 | 319 | 0.080 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 204 | 0.080 |
Why?
|
| Kinesthesis | 1 | 2007 | 6 | 0.080 |
Why?
|
| Video Recording | 1 | 2009 | 267 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2007 | 52 | 0.080 |
Why?
|
| Joints | 1 | 2007 | 47 | 0.080 |
Why?
|
| Proprioception | 1 | 2007 | 21 | 0.080 |
Why?
|
| Cell Proliferation | 6 | 2023 | 7226 | 0.080 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2007 | 11 | 0.080 |
Why?
|
| Cicatrix, Hypertrophic | 1 | 2007 | 9 | 0.080 |
Why?
|
| Luciferases | 1 | 2008 | 445 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 470 | 0.070 |
Why?
|
| Fracture Healing | 1 | 2007 | 40 | 0.070 |
Why?
|
| Breast | 1 | 2013 | 1344 | 0.070 |
Why?
|
| Feedback | 1 | 2007 | 198 | 0.070 |
Why?
|
| Mutation | 4 | 2023 | 15179 | 0.070 |
Why?
|
| Smoking | 1 | 2016 | 2440 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2012 | 2292 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2014 | 2173 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2010 | 369 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 2864 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 311 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 5539 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2017 | 9180 | 0.070 |
Why?
|
| Fibroblasts | 2 | 2022 | 1682 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2007 | 266 | 0.070 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2005 | 11 | 0.070 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2006 | 20 | 0.070 |
Why?
|
| Bicuculline | 1 | 2005 | 55 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2016 | 830 | 0.070 |
Why?
|
| Hearing | 1 | 2005 | 64 | 0.070 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 13658 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2011 | 795 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2017 | 1724 | 0.070 |
Why?
|
| Aneurysm | 1 | 2006 | 94 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 703 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 292 | 0.070 |
Why?
|
| Osteogenesis, Distraction | 1 | 2005 | 36 | 0.070 |
Why?
|
| Intracranial Thrombosis | 1 | 2005 | 17 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2007 | 319 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2016 | 2819 | 0.060 |
Why?
|
| Brain Stem | 1 | 2006 | 175 | 0.060 |
Why?
|
| Cerebral Revascularization | 1 | 2005 | 23 | 0.060 |
Why?
|
| Lymph Node Excision | 2 | 2022 | 1959 | 0.060 |
Why?
|
| Macrophages | 3 | 2016 | 1304 | 0.060 |
Why?
|
| Efferent Pathways | 1 | 2004 | 9 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2012 | 1270 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 6 | 2013 | 6942 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 1375 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 651 | 0.060 |
Why?
|
| Chondrocytes | 2 | 2015 | 107 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 399 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2007 | 435 | 0.060 |
Why?
|
| Intracranial Aneurysm | 1 | 2005 | 123 | 0.060 |
Why?
|
| Somatostatin | 1 | 2024 | 114 | 0.060 |
Why?
|
| Beauty | 1 | 2023 | 14 | 0.060 |
Why?
|
| Transfection | 1 | 2008 | 2944 | 0.060 |
Why?
|
| Rats, Inbred Lew | 2 | 2013 | 113 | 0.060 |
Why?
|
| Neurophysiology | 1 | 2023 | 20 | 0.060 |
Why?
|
| Thrombospondin 1 | 1 | 2023 | 55 | 0.060 |
Why?
|
| Placenta | 1 | 2007 | 516 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2019 | 2803 | 0.050 |
Why?
|
| Cell Count | 2 | 2018 | 508 | 0.050 |
Why?
|
| Biomarkers | 3 | 2023 | 5047 | 0.050 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 1105 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2018 | 1987 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2006 | 403 | 0.050 |
Why?
|
| Cell Division | 3 | 2016 | 2489 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2022 | 257 | 0.050 |
Why?
|
| Single-Blind Method | 2 | 2018 | 409 | 0.050 |
Why?
|
| Homozygote | 1 | 2023 | 717 | 0.050 |
Why?
|
| Centrifugation | 1 | 2021 | 66 | 0.050 |
Why?
|
| Pericytes | 1 | 2022 | 96 | 0.050 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2022 | 305 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8873 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2022 | 137 | 0.050 |
Why?
|
| Herniorrhaphy | 1 | 2023 | 169 | 0.050 |
Why?
|
| Fingers | 1 | 2021 | 120 | 0.050 |
Why?
|
| Self-Help Devices | 1 | 2020 | 15 | 0.050 |
Why?
|
| Age Distribution | 2 | 2013 | 698 | 0.050 |
Why?
|
| Acute Disease | 1 | 2006 | 2422 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2007 | 787 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 183 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2023 | 875 | 0.050 |
Why?
|
| Mitochondria | 2 | 2018 | 1282 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 403 | 0.050 |
Why?
|
| Eye Movements | 1 | 2020 | 116 | 0.050 |
Why?
|
| Sleep | 1 | 2023 | 413 | 0.050 |
Why?
|
| Ohio | 1 | 2020 | 113 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2022 | 330 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2018 | 11965 | 0.050 |
Why?
|
| Deferoxamine | 2 | 2010 | 28 | 0.050 |
Why?
|
| Vision, Ocular | 1 | 2020 | 157 | 0.040 |
Why?
|
| Axilla | 1 | 2022 | 902 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2017 | 5061 | 0.040 |
Why?
|
| Umbilical Veins | 2 | 2009 | 115 | 0.040 |
Why?
|
| Animals, Newborn | 2 | 2018 | 1338 | 0.040 |
Why?
|
| Cell Survival | 2 | 2015 | 3045 | 0.040 |
Why?
|
| Sarcoma, Ewing | 2 | 2014 | 406 | 0.040 |
Why?
|
| Myelin Basic Protein | 1 | 2018 | 85 | 0.040 |
Why?
|
| Autografts | 1 | 2019 | 165 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2015 | 4078 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 987 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 360 | 0.040 |
Why?
|
| Gene Expression | 1 | 2007 | 3570 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1362 | 0.040 |
Why?
|
| Propensity Score | 1 | 2021 | 750 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2019 | 157 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2018 | 151 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 2018 | 78 | 0.040 |
Why?
|
| Contrast Media | 2 | 2020 | 1472 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 1244 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 600 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2019 | 285 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 788 | 0.040 |
Why?
|
| Nucleotides | 1 | 2018 | 164 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 2359 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 2018 | 52 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2018 | 149 | 0.040 |
Why?
|
| Vascular Grafting | 1 | 2018 | 50 | 0.040 |
Why?
|
| Medicare | 1 | 2022 | 860 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 187 | 0.040 |
Why?
|
| Neck Dissection | 1 | 2018 | 290 | 0.040 |
Why?
|
| Ketoglutaric Acids | 1 | 2017 | 38 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 32 | 0.040 |
Why?
|
| Pregnancy Proteins | 1 | 2017 | 44 | 0.040 |
Why?
|
| Biocatalysis | 1 | 2017 | 63 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2018 | 269 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2018 | 280 | 0.040 |
Why?
|
| Transaminases | 1 | 2017 | 76 | 0.040 |
Why?
|
| Cheek | 1 | 2017 | 70 | 0.040 |
Why?
|
| NADP | 1 | 2017 | 96 | 0.040 |
Why?
|
| Composite Tissue Allografts | 1 | 2016 | 7 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2007 | 6150 | 0.040 |
Why?
|
| Parietal Bone | 1 | 2016 | 18 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 110 | 0.040 |
Why?
|
| Fetal Development | 1 | 2018 | 120 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2018 | 726 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2017 | 94 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 588 | 0.040 |
Why?
|
| Nerve Crush | 1 | 2016 | 9 | 0.040 |
Why?
|
| Intersectoral Collaboration | 1 | 2016 | 44 | 0.040 |
Why?
|
| Registries | 2 | 2016 | 2170 | 0.040 |
Why?
|
| Optic Nerve Injuries | 1 | 2016 | 12 | 0.030 |
Why?
|
| Phenotype | 3 | 2017 | 6295 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 476 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2016 | 224 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 980 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2018 | 245 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2018 | 717 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2016 | 112 | 0.030 |
Why?
|
| Cell Shape | 1 | 2016 | 128 | 0.030 |
Why?
|
| Silicones | 1 | 2015 | 54 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2015 | 3033 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2023 | 1154 | 0.030 |
Why?
|
| Osteosarcoma | 2 | 2014 | 929 | 0.030 |
Why?
|
| Fetus | 1 | 2019 | 601 | 0.030 |
Why?
|
| Endotoxemia | 1 | 2016 | 61 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 164 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2010 | 621 | 0.030 |
Why?
|
| Osteocytes | 1 | 2015 | 27 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 519 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2018 | 295 | 0.030 |
Why?
|
| Pituitary Hormones | 1 | 2014 | 14 | 0.030 |
Why?
|
| Biopsy | 1 | 2023 | 3443 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 324 | 0.030 |
Why?
|
| Chitosan | 1 | 2015 | 79 | 0.030 |
Why?
|
| Microspheres | 1 | 2015 | 210 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2020 | 666 | 0.030 |
Why?
|
| Movement Disorders | 2 | 2010 | 232 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2022 | 929 | 0.030 |
Why?
|
| Perfusion | 1 | 2016 | 293 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 1046 | 0.030 |
Why?
|
| Leiomyosarcoma | 1 | 2016 | 223 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 957 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 699 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 280 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 915 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 2146 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 1085 | 0.030 |
Why?
|
| Radius | 1 | 2014 | 42 | 0.030 |
Why?
|
| Humerus | 1 | 2014 | 53 | 0.030 |
Why?
|
| Diabetic Nephropathies | 1 | 2016 | 183 | 0.030 |
Why?
|
| Rats, Inbred BN | 1 | 2013 | 34 | 0.030 |
Why?
|
| Glycerol | 1 | 2014 | 99 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 413 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1489 | 0.030 |
Why?
|
| San Francisco | 1 | 2013 | 19 | 0.030 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2014 | 52 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 1620 | 0.030 |
Why?
|
| Cell Separation | 1 | 2015 | 612 | 0.030 |
Why?
|
| Foreign-Body Reaction | 1 | 2013 | 27 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 1084 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 558 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 263 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 694 | 0.030 |
Why?
|
| Tissue and Organ Procurement | 1 | 2016 | 233 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 668 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1559 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 918 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2019 | 1863 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 829 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 598 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 769 | 0.030 |
Why?
|
| Apoptosis | 1 | 2007 | 7591 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 3101 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2009 | 2450 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2017 | 3869 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2020 | 3552 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2016 | 5710 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2012 | 136 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2013 | 495 | 0.030 |
Why?
|
| Torso | 1 | 2012 | 73 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2015 | 583 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 475 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 206 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2014 | 1391 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 2012 | 167 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 671 | 0.020 |
Why?
|
| Sensation Disorders | 1 | 2010 | 27 | 0.020 |
Why?
|
| Durapatite | 1 | 2010 | 31 | 0.020 |
Why?
|
| Siderophores | 1 | 2010 | 11 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2010 | 52 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2020 | 10331 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 73 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2012 | 362 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2020 | 2669 | 0.020 |
Why?
|
| Pyruvaldehyde | 1 | 2009 | 10 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2010 | 116 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3821 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 1498 | 0.020 |
Why?
|
| Esophagectomy | 1 | 2014 | 911 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 6311 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2009 | 8 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 672 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3981 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2009 | 110 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 390 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1819 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 703 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 328 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 482 | 0.020 |
Why?
|
| Abbreviated Injury Scale | 1 | 2007 | 8 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2009 | 309 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 224 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 634 | 0.020 |
Why?
|
| Hematoma, Subdural | 1 | 2007 | 28 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 300 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 5687 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2009 | 423 | 0.020 |
Why?
|
| Colorimetry | 1 | 2007 | 31 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 2843 | 0.020 |
Why?
|
| Elasticity | 1 | 2007 | 156 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 521 | 0.020 |
Why?
|
| Curriculum | 1 | 2012 | 860 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2009 | 333 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 207 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2012 | 671 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2007 | 682 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 1818 | 0.020 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2005 | 63 | 0.020 |
Why?
|
| Swine | 1 | 2009 | 1541 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 3260 | 0.020 |
Why?
|
| Brain Damage, Chronic | 1 | 2005 | 37 | 0.020 |
Why?
|
| Case Management | 1 | 2005 | 35 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1070 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2007 | 225 | 0.020 |
Why?
|
| Prostaglandins | 1 | 2004 | 77 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2005 | 95 | 0.020 |
Why?
|
| Laminin | 1 | 2004 | 194 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2004 | 128 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 1489 | 0.010 |
Why?
|
| Body Temperature | 1 | 2004 | 158 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 259 | 0.010 |
Why?
|
| Glucose | 1 | 2009 | 1248 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 4367 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 14551 | 0.010 |
Why?
|
| Protein Binding | 1 | 2009 | 3438 | 0.010 |
Why?
|
| Headache | 1 | 2003 | 163 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2005 | 292 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 1493 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 3203 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2006 | 1656 | 0.010 |
Why?
|
| DNA Replication | 1 | 2004 | 744 | 0.010 |
Why?
|
| Embolization, Therapeutic | 1 | 2005 | 551 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 2054 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 2809 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2005 | 1274 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 6915 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 4143 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2003 | 1162 | 0.010 |
Why?
|